taking semaglutide for weight loss (Ozempic® & Wegovy®) Before and After Results: Timelines (2026) Semaglutide Weight Loss: How Does

Medical Monitoring Regular assessment of bone health is essential for those on GLP-1 medications: Baseline DEXA scan : Consider getting a bone density test before starting GLP-1 medication Follow-up testing : Repeat every 1-2 years while on medication Blood tests : Check vitamin D, calcium, and bone turnover markers annually Height measurement : Loss of height can be an early warning sign of vertebral fractures Conclusion GLP-1 medications offer powerful benefits for weight management and diabetes control

Some studies report losses of between 3.5 and 5.7 kg ( Few observational studies have explored kidney outcomes in patients treated with OWS, and short-term follow-up may be insufficient to detect changes in the eGFR ( Insulin dose reduction is another reported finding in some real-world experiences ( GLP1-RA is notorious for its gastrointestinal adverse events (AEs)

Ozempic and Rybelsus are FDA-approved for treating type 2 diabetes, while Wegovy is FDA-approved for weight loss and weight management

5 There is some evidence to suggest that GIP could reduce side effects from GLP-1 drugs, however, these findings are from animal studies